Chinook Therapeutics Inc (KDNY) has fallen Wednesday morning, with the stock falling -5.89% in pre-market trading to 14.22. KDNY's short-term technical score of 90 indicates that the stock has traded more bullishly over the last month than 90% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, KDNY ranks higher than 96% of stocks. Chinook Therapeutics Inc has risen 1.68% over the past month, closing at $14.46 on April 27. During this period of time, the stock fell as low as $12.59 and as high as $16.87. KDNY has an average analyst recommendation of Strong Buy. The company has an average price target of $31.50.
KDNY has an Overall Score of 80. Find out what this means to you and get the rest of the rankings on KDNY!